Navigation Links
Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
Date:10/16/2007

to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualified in their entirety by this cautionary statement.


'/>"/>
SOURCE Anesiva, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Sygnis Pharma AG announces date for presentation of clinical results
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)...ctober 7 /-,Sosei Group Cor...ctura,Group plc ("Vectura"; LSE: VEC), announce re...acy, safety and tolerability of NVA237 presented a...Society (ERS) in Berlin,Germany. The new data sho...haled long-acting muscarinic antagonist (LAMA), pr...
(Date:10/6/2008)...to the understanding of and possible trea...BILLERICA, Mass., Oct. 6 /- Seahorse ...t ever analytical instrument for the,kinetic measu...oplasmic,glycolysis in cells in a 96 well micropla...ular bioenergetics have been relatively unchanged ...
(Date:10/6/2008)... at The American College of Nutrition ...6 /- New research on the benefits of,...t The American College of,Nutrition (ACN) Annual M...Probiotics in Health and Disease." Scientific expe...ion discussed the potential uses for,probiotics in...
(Date:10/6/2008)...E, Oct. 6 /- Complete,Genomics Inc., ...quencing,company, and the Institute for Systems Bi...onduct populationwide human genome studies., In p...e its proprietary,DNA sequencing technology to seq...hen, once proof-of-concept has been demonstrated, ...
Breaking Medicine Technology:NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 2NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 3NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 5Seahorse Bioscience Announces the XF96 Extracellular Flux Analyzer for Cellular Bioenergetics 2Seahorse Bioscience Announces the XF96 Extracellular Flux Analyzer for Cellular Bioenergetics 3'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 2'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 3'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 4Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome Population Study 2New study in the journal Sleep finds that catathrenia can be successfully treated with CPAP 8958 1New study in the journal Sleep finds that catathrenia can be successfully treated with CPAP 8958 2New study in the journal Sleep finds that catathrenia can be successfully treated with CPAP 8958 3Journal Sleep 3A A short term dose of zolpidem is an effective treatment for insomnia 8956 1Journal Sleep 3A A short term dose of zolpidem is an effective treatment for insomnia 8956 2Research suggests new treatment suitable for all patients 8954 1Research suggests new treatment suitable for all patients 8954 2Research suggests new treatment suitable for all patients 8954 3Silence may lead to phantom noises misinterpreted as tinnitus 8952 1
(Date:10/7/2008)... Moores Cancer Center at the University of Califor...ave off the relentless march of advanced lung canc...r vaccine. While many vaccines attempt to pump up ...accine, Lucanix, is genetically engineered to also...em-suppressing activities. , The first patients ...
(Date:10/7/2008)...ment of planned bequest comes at stem cell symposi...re/ -- Just over one year,ago, retail pioneer A. A...University of Michigan, to endow a new research in...nting human disease., Today, at the institute,s f... he will bequeath an additional $22 million to the...
(Date:10/7/2008)...0 PEOPLE ACROSS THE NATION HAVE SAID ,I VOTE FOR T...S, Oct. 7 /PRNewswire/ -- To aid and help educate ... positions of presidential candidates,Senators Joh...ancer issues,the Susan G. Komen for the Cure(R) A...ces available on its web site --, http://www.IVote...
(Date:10/7/2008)... Wyndstorm Corporation ( www.wyndstorm.com ) ...ompany, announced a key win with Muve, Inc. ( www....plan program design to promote Muve,s activity-bas...project will ultimately help Muve,s corporate clie...oyees via interactive messaging, rewards programs,...
Breaking Medicine News(10 mins):Health News:Novel Lung Cancer Vaccine Trial Launched at Moores UCSD Cancer Center 2Health News:Alfred Taubman Announces New $22M Gift to U-M 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Educates Voters, Debate Watchers on McCain/Obama Health Care Agendas 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Educates Voters, Debate Watchers on McCain/Obama Health Care Agendas 3Health News: 3D Social Media Application Aims to Cut Workplace Obesity : Muve, Inc., Selects Social Media Developer Wyndstorm Corporation to Design Online Promotions for Corporate Wellness Program 2Health News: 3D Social Media Application Aims to Cut Workplace Obesity : Muve, Inc., Selects Social Media Developer Wyndstorm Corporation to Design Online Promotions for Corporate Wellness Program 3
...claim to the highest autism rate in America, have ...to autism and provide lifetime care for those wit...utism, the largest so far, has found that about 1 ...est rate 1 in 94 children found in New Jersey. ...
...tronic nose device which may be used to diagnose t...s at Leiden University Medical Center in the Nethe... a newer version of a sensor that has been used in...es, contains chemical vapour sensors that react to...
...male impotence drug Viagra may be useful for treat...r the treatment of high blood pressure and angina,...levels of a naturally-occurring compound, cyclic g...GMP). In the brain, cGMP has a vital function in ...
...that topical application of a gel made from platel...ds heal more quickly and completely . Recent inno... into a concentrated plasma rich in platelets (par...), and then to an autologous (from the patients ow...
Other Medicine News:Health News:American State Lawmakers Make Moves To Tackle Autism 2Health News:Electronic Nose to Diagnose the Severity of Asthma 2Health News:Gel Made of Patients Own Platelets may Speed Up Wound Healing 2
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
Medicine Products: